PREDICTING THE RISK OF GRAVES DISEASE RELAPSE: COMMENTARY ON "THYROID PEROXIDASE ANTIBODY POSITIVITY IS ASSOCIATED WITH RELAPSE-FREE SURVIVAL FOLLOWING ANTITHYROID DRUG TREATMENT FOR GRAVES DISEASE"

被引：0
|
作者：
Gallo, D. [1 ]
Tanda, M. L. [1 ]
Piantanida, E. [1 ,2 ]
机构：
[1] Univ Insubria, Dept Med & Surg, Endocrine Unit, Viale Borri 57, I-21100 Varese, Italy
[2] ASST Sette Laghi, Viale Borri 57, I-21100 Varese, Italy
来源：
ENDOCRINE PRACTICE | 2020年 / 26卷 / 09期
关键词：
HYPERTHYROIDISM; THERAPY;
D O I：
10.4158/EP-2020-0230
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1039 / 1041
页数：3
相关论文
共 28 条
  • [21] HIGH THYROPEROXIDASE ANTIBODY TITERS MAY PREDICT RESPONSE TO ANTITHYROID DRUG TREATMENT IN GRAVES DISEASE: A PRELIMINARY STUDY
    Gokbulut, P.
    Koc, G.
    Kuskonmaz, S. M.
    Onder, C. E.
    Omma, T.
    Firat, S.
    Culha, C.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2023, 19 (02) : 195 - 200
  • [22] Age May Influence the Impact of TRAbs on Thyroid Function and Relapse-Risk in Patients With Graves Disease
    Bano, Arjola
    Gan, Earn
    Addison, Caroline
    Narayanan, Kilimangalam
    Weaver, Jolanta U.
    Tsatlidis, Vasileios
    Razvi, Salman
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (05) : 1378 - 1385
  • [23] Long-Term Antithyroid Drug Treatment: Trends in Serum TSH and TSH Receptor Antibody Changes in Patients with Graves' Disease
    Okamura, Ken
    Bandai, Sachiko
    Fujikawa, Megumi
    Sato, Kaori
    Ikenoue, Hiroshi
    Kitazono, Takanari
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2020, 18
  • [24] High Thyroid Stimulating Receptor Antibody Titre and Large Goitre Size at First-Time Radioactive Iodine Treatment are Associated with Treatment Failure in Graves' Disease
    Tay, Wei Lin
    Chng, Chiaw Ling
    Tien, Carolyn S. Y.
    Loke, Kelvin S. H.
    Lam, Winnie W. C.
    Fook-Chong, Stephanie M. C.
    Tong, Aaron K. T.
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2019, 48 (06) : 181 - 187
  • [25] Development of anti-neutrophil cytoplasmic antibody-associated vasculitis in a patient with Graves' disease independent of anti-thyroid drug therapy
    Khan, Nasim Ahmed
    Singh, Manisha
    MODERN RHEUMATOLOGY, 2012, 22 (05) : 778 - 782
  • [26] Risk factors predicting graft-versus-host disease and relapse-free survival after allogeneic hematopoietic stem cell transplantation in relapsed or refractory non-Hodgkin's lymphoma
    Jeon, Young-Woo
    Yoon, Seugyun
    Min, Gi June
    Park, Sung-Soo
    Park, Silvia
    Yoon, Jae-Ho
    Lee, Sung-Eun
    Cho, Byung-Sik
    Eom, Ki-Seong
    Kim, Yoo-Jin
    Kim, Hee-Je
    Lee, Seok
    Min, Chang-Ki
    Lee, Jong Wook
    Cho, Seok-Goo
    ANNALS OF HEMATOLOGY, 2019, 98 (07) : 1743 - 1753
  • [27] Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia
    Kang, Huining
    Chen, I. -Ming
    Wilson, Carla S.
    Bedrick, Edward J.
    Harvey, Richard C.
    Atlas, Susan R.
    Devidas, Meenakshi
    Mullighan, Charles G.
    Wang, Xuefei
    Murphy, Maurice
    Ar, Kerem
    Wharton, Walker
    Borowitz, Michael J.
    Bowman, W. Paul
    Bhojwani, Deepa
    Carroll, William L.
    Camitta, Bruce M.
    Reaman, Gregory H.
    Smith, Malcolm A.
    Downing, James R.
    Hunger, Stephen P.
    Willman, Cheryl L.
    BLOOD, 2010, 115 (07) : 1394 - 1405
  • [28] Free Thyroxine, Anti-Thyroid Stimulating Hormone Receptor Antibody Titers, and Absence of Goiter Were Associated with Responsiveness to Methimazole in Patients with New Onset Graves' Disease
    Choi, Hoon Sung
    Yoo, Won Sang
    ENDOCRINOLOGY AND METABOLISM, 2017, 32 (02) : 281 - 287
123